Antiviral activity of Cirsium japonicum var. spinossimum extract and its flavonoid cirsimaritin against human coronavirus OC43
Journal of Microbiology · 2026
DOI: 10.71150/jm.2608018 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Microbiology, 2026. Verfasst von Chunghyeon Lee und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Biological Science and Technology, Yonsei University, Wonju 26493, Republic of Korea. Hauptthemen laut MEDLINE: Antiviral Agents, Plant Extracts, Cirsium, Coronavirus OC43, Human. Die Arbeit nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Rural Development Administration.
Abstract (Originalsprache)
Coronaviruses cause a wide range of diseases, ranging from the common cold to severe illnesses such as COVID-19. Although vaccines and therapeutics against COVID-19 have been developed, recent reports have documented the emergence of viral variants with reduced susceptibility to these interventions, suggesting that coronaviruses may continue to circulate persistently, similar to influenza viruses. Cirsium japonicum var. spinossimum Kitam. (hereafter referred to as C. japonicum) has traditionally been used to treat various medical conditions, including inflammatory diseases; however, its antiviral properties remain poorly understood. In this study, we demonstrated that C. japonicum extract inhibited human coronavirus replication and alleviated virus-induced cytotoxicity. Analysis of the chemical constituents of the extract identified cirsimaritin, a major flavonoid present in C. japonicum, as an active compound with antiviral activity against human coronavirus. The antiviral effects of both C. japonicum extract and cirsimaritin were further confirmed using scanning electron microscopy and a three-dimensional spheroid model. Finally, we demonstrated that C. japonicum extract and cirsimaritin inhibited coronavirus papain-like protease activity. These findings suggest that C. japonicum extract and cirsimaritin have potential as therapeutic candidates for coronavirus-associated diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Biological Science and Technology, Yonsei University, Wonju 26493, Republic of Korea.
- Department of Herbal Crop Research, National Institute of Horticultural & Herbal Science, RDA, Eumsung 27709, Republic of Korea.
- R&D team, Korea Mine Rehabilitation and Mineral Resources Corporation, Wonju 26464, Republic of Korea.
Förderung
- Rural Development Administration
Zitieren
APA
Lee, C., Kim, J. H., Lee, S., Cho, S., Kim, S., Park, J., Kim, Y. G., & Park, J. (2026). Antiviral activity of Cirsium japonicum var. spinossimum extract and its flavonoid cirsimaritin against human coronavirus OC43. Journal of Microbiology. https://doi.org/10.71150/jm.2608018
Vancouver
Lee C, Kim JH, Lee S, Cho S, Kim S, Park J, et al. Antiviral activity of Cirsium japonicum var. spinossimum extract and its flavonoid cirsimaritin against human coronavirus OC43. Journal of Microbiology. 2026. doi:10.71150/jm.2608018
BibTeX
@article{Lee2026,
author = {Lee, Chunghyeon and Kim, Jang Hoon and Lee, Siyun and Cho, Seungju and Kim, Sumin and Park, Jayhyun and Kim, Yong-Goo and Park, Junsoo},
title = {Antiviral activity of Cirsium japonicum var. spinossimum extract and its flavonoid cirsimaritin against human coronavirus OC43},
journal = {Journal of Microbiology},
year = {2026},
doi = {10.71150/jm.2608018}
}
EUVIMED